CRISM national guideline for the clinical management of opioid use disorder

This guideline lays out the optimal strategies for the treatment of opioid addiction and recommends opioid agonist treatment with buprenorphine-naloxone as the preferred first-line treatment.

Image
Article icon

Published by

Canadian Research Initiative in Substance Misuse (CRISM)

Date

Language(s)

English, French

Population(s)

People who inject or use drugs

Audience

Program tools

Resource Type

Guideline or manual